Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.300
-0.130 (-2.93%)
Aug 12, 2026, 2:37 PM EDT - Market open

IMDX Revenue

Insight Molecular Diagnostics had revenue of $239.00K in the quarter ending June 30, 2026, a decrease of -53.86%. This brings the company's revenue in the last twelve months to $1.67M, down -60.77% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth.

Revenue (ttm)
$1.67M
Revenue Growth
-60.77%
P/S Ratio
83.14
Revenue / Employee
$28,793
Employees
58
Market Cap
138.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.06M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
OPKO Health587.90M
Castle Biosciences357.28M
Fulgent Genetics323.93M
MDxHealth110.97M
Biodesix102.94M
Burning Rock Biotech74.58M
Exagen71.12M
Revenue Rankings